Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Position Trimmed by First Trust Advisors LP

Posted by Defense World Staff on Mar 10th, 2023

First Trust Advisors LP cut its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) by 33.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 209,401 shares of the company’s stock after selling 103,180 shares during the quarter. First Trust Advisors LP owned approximately 0.23% of Acadia Healthcare worth $16,371,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Altshuler Shaham Ltd acquired a new stake in shares of Acadia Healthcare in the 3rd quarter worth about $26,000. Point72 Hong Kong Ltd acquired a new stake in shares of Acadia Healthcare in the first quarter valued at approximately $38,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Acadia Healthcare during the second quarter valued at approximately $39,000. First Horizon Advisors Inc. boosted its position in shares of Acadia Healthcare by 87.2% during the third quarter. First Horizon Advisors Inc. now owns 846 shares of the company’s stock worth $66,000 after buying an additional 394 shares during the period. Finally, IFP Advisors Inc raised its stake in Acadia Healthcare by 51.3% during the 3rd quarter. IFP Advisors Inc now owns 876 shares of the company’s stock valued at $54,000 after acquiring an additional 297 shares in the last quarter. 99.79% of the stock is currently owned by institutional investors.

Acadia Healthcare Price Performance

NASDAQ ACHC opened at $69.99 on Friday. The company has a 50 day simple moving average of $80.89 and a 200-day simple moving average of $81.81. Acadia Healthcare Company, Inc. has a 52-week low of $62.32 and a 52-week high of $89.85. The firm has a market capitalization of $6.39 billion, a price-to-earnings ratio of 23.33, a price-to-earnings-growth ratio of 1.53 and a beta of 1.31. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.30 and a quick ratio of 1.30.

Analyst Ratings Changes

A number of brokerages have issued reports on ACHC. Royal Bank of Canada decreased their price target on Acadia Healthcare from $94.00 to $93.00 and set an “outperform” rating for the company in a research note on Monday, December 12th. Deutsche Bank Aktiengesellschaft reduced their price objective on Acadia Healthcare from $82.00 to $75.00 and set a “hold” rating for the company in a research note on Monday. Mizuho cut their target price on Acadia Healthcare from $87.00 to $80.00 and set a “neutral” rating on the stock in a research report on Monday. Loop Capital raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $90.00 to $95.00 in a research note on Monday, December 12th. Finally, Stephens reduced their price objective on shares of Acadia Healthcare from $92.00 to $88.00 and set an “equal weight” rating for the company in a research note on Wednesday, March 1st. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $89.67.

Acadia Healthcare Company Profile

(Get Rating)

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services.